Charles River Laboratories

formerly Charles River Laboratories InternationalIPO

Charles River Laboratories | Because every moment matters

Public · Wilmington, United States · Founded 1947 · $443.0M raised

Employees
10001+
Founded
1947
Business Model
B2B
Website
criver.com
Total Funding
$443.0M
Last Round
$443.0M Private EquitySep 1999
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Charles River Laboratories is a leading global contract research organization (CRO) that provides essential products and services to pharmaceutical, biotechnology, government, and academic clients to accelerate the discovery, early-stage development, and safe manufacture of novel drugs and therapeutics. Founded in 1947 in Boston, the company has grown from a single laboratory into a global strategic partner with over 15,000 employees across 6 continents. Its capabilities span safety assessment, discovery services, biologics testing, microbial solutions, and research model supply, enabling clients to progress from target identification through IND-enabling studies and into clinical manufacturing.

Summary

Charles River Laboratories is a Biotech company based in Wilmington, United States, founded in 1947. It has raised $443.0M in total across 1 round, most recently a $443.0M Private Equity round in Sep 1999. Investors include DLJ Merchant Banking Partners and Global Health Care Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOMar 2004
$224.0M

Sign up to see all 3 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Charles River Laboratories on Indexed.vc
<a href="https://indexed.vc/companies/charles-river-laboratories"><img src="https://indexed.vc/api/badge/company/charles-river-laboratories" alt="Charles River Laboratories on Indexed.vc" width="260" height="76" /></a>